Cooperatief H2/Primacy Healthcare 21 (Aquilant)
Transaction details
The proposed acquisition by Cooperatief H2 Equity Partners Fund V U.A and Primacy Healthcare 21 Holding Company Unlimited Company of joint control of Primacy Healthcare 21 Limited, and the proposed acquisition of sole control of Healthcare Acquisition Limited by Primacy Healthcare 21 Limited, was cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:22 August 2018
- Publication date:22 August 2018
- Economic sector:Wholesale & retail trade - G
- Economic sub-sector:Wholesale trade - G.46
- Outcome:Cleared
Documents
M.18.070 Merger AnnouncementPDF | 116 KBM.18.070 Merger Announcement PDF | 116 KB - Opens in new window
M.18.070 DeterminationPDF | 270 KBM.18.070 Determination PDF | 270 KB - Opens in new window
Timetable
Parties Involved
Cooperatief H2 Equity Partners Fund V U.A
Cooperatief H2 Equity Partners Fund V U.A is a private equity fund focused on making investments in the UK and Ireland, as well as in the Benelux region.
Primacy Healthcare 21 Limited
Primacy Healthcare 21 Limited is a privately owned healthcare company with operations in the UK, Germany, Austria and Ireland. The company provides sales, marketing, customer services, engineering services and logistics for a variety of medical technology manufacturers.
Healthcare Acquisition Limited
Healthcare Acquisition Limited controls the Aquilant group of companies which provide specialist healthcare and scientific products and services, as well as sales, marketing, distribution and engineering for the medical and scientific sectors.
Contacts
Tommy Burke tommyburke@ccpc.ie
